Notes
2012 British pounds
ovarian cancer
Reference
Manchanda R, et al. Specifying the ovarian cancer risk threshold of 'premenopausal risk-reducing salpingo-oophorectomy' for ovarian cancer prevention: a cost-effectiveness analysis. Journal of Medical Genetics : 27 Jun 2016. Available from: URL: http://dx.doi.org/10.1136/jmedgenet-2016-103800
Rights and permissions
About this article
Cite this article
RRSO cost effective at ≥4% risk of ovarian cancer. PharmacoEcon Outcomes News 757, 28 (2016). https://doi.org/10.1007/s40274-016-3217-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3217-8